Hypoxia-inducible factors (HIFs) are transcriptional regulators that mediate the cellular response to low oxygen levels. By stimulating the expression of angiogenic growth factors such as vascular endothelial growth factor (VEGF), they trigger the neovascularization of tissues under physiological and pathological conditions. Here, we have investigated the endothelial cell autonomous HIF function in blood vessel growth and development, by expressing a dominant negative HIF mutant (HIFdn) that inhibits the transcriptional responses mediated by both HIF-1 and HIF-2, specifically in endothelial cells of transgenic mice. HIFdn transgenic embryos were growth retarded and died around E11.5. Primitive vascular networks were established, but vascular remodeling in the yolk sac and in the embryo proper was defective, and vascular sprouts failed to invade the neuroepithelium. In addition, heart looping was incomplete, and the ventricles of the heart were thin-walled and lacked trabeculation. Similar cardiovascular defects have been observed in Tie-2 deficient mouse embryos.
Introduction
Growing tissues have a continuous demand for oxygen and nutrients. Tissue hypoxia efficiently triggers the growth of new blood vessels in both physiological and pathological processes. For example, hypoxia stimulates the compensatory formation of blood vessels in coronary heart disease, stroke, or in tumors, by up-regulating the expression of angiogenic factors such as vascular endothelial growth factor (VEGF) 1, 2 . It has also been suggested that during embryonic vessel development, regions of relative hypoxia attract growing blood vessels 3 . The cellular responses to low oxygen levels are mediated by transcription factors called hypoxia-inducible factors (HIF). At present, three different HIF family members are known: HIF-1, HIF-2 and HIF-3. HIFs are heterodimers composed of one of three different HIF-subunits, HIF-1 4 , HIF-2 [5] [6] [7] or HIF-3 8, 9 , and the common HIF-1 (ARNT) subunit.
Under normoxic conditions, the HIF-subunits are rapidly degraded. This process involves the posttranslational modification of HIF-by a recently discovered family of prolyl hydroxylases (PHD) 10 . Hydroxylated prolyl residues of the HIF-subunits are recognized by the von-Hippel-Lindau protein, a part of the E3 ubiquitin ligase complex that marks the HIFsubunits for degradation by the proteasome [11] [12] [13] . Under hypoxic conditions, PHD are inactive, and HIF-subunits accumulate in the nucleus, where they transactivate their target genes. In addition, growth factor signaling modulates HIF activity and stability in a hypoxia independent fashion 10, 14 . Whereas HIF-1 is expressed ubiquitously, HIF-2 and HIF-3
show a spatially restricted expression pattern, HIF-2 being predominantly expressed in endothelial cells during ontogeny [5] [6] [7] .
HIF-1 and HIF-2 stimulate the expression of essential endothelial receptor tyrosine kinases, such as Tie-2, Flt-1, and Flk-1 7, [15] [16] [17] . A recent study characterized the transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1 in vitro 18 . Collectively, these data suggest that HIF-1 and HIF-2 exert important functions in endothelial cells and showed impaired extra-and intra-embryonic vessel formation, defective neural tube closure, and increased mesenchymal cell death, leading to embryonic death around E10 [19] [20] [21] .
However, the endothelial cell selective loss of HIF-1 did not affect vascular development, but rather pathological angiogenesis in the adult mouse 22 . This suggested that HIF-1 exerts its function in embryonic angiogenesis primarily by regulating paracrine factors such as VEGF, rather than by stimulating endothelial cell intrinsic processes. Unexpectedly, several independent studies reported that the targeted inactivation of HIF-2 did not affect mouse embryonic vascular development: HIF-2 deficient embryos died from defective catecholamine metabolism and bradycardia 23 , suffered from defects in neonatal lung maturation 24 , or developed a syndrome of multiple-organ pathology and biochemical abnormalities 25 . Only one group reported vascular defects in the yolk sac vasculature which was rescued by HIF-2 26, 27 . Thus, it remained unclear whether HIFs have an essential function in endothelial cells during vascular development, or whether functional redundancy within the HIF family obscured such a function.
Here, we report that HIF activity in endothelial cells is essential for embryonic blood vessel development. HIF-mediated gene transcription was blocked by the expression of a dominant-negative HIF mutant (HIFdn) that inhibited the activity of both HIF-1-and HIF-2.
HIFdn expression was directed to endothelial cells of transgenic mice from promoter/enhancer regions of the flk-1 gene (flk-1 p/e). The flk-1 p/e-HIFdn transgenic embryos were severely growth retarded, had multiple cardiovascular defects and died around E11.5. The expression of the angiopoietin receptor, Tie-2, was greatly reduced in these mice. These results establish an essential role for endothelial hypoxia-inducible factors in the formation of the heart, in angiogenic sprouting, and in the remodeling of the embryonic vascular system.
Material and methods
Cell culture and firefly luciferase reporter gene assays. HEK293 cells were cultured in 30, 31 . Primers for VEGF were VEGF forw 5' CTGCTCTCTT GGGTGCACTGG 3'
and VEGF rev 5' CACCGCCTTG GCTTGTCACAT 3'. Expression of the HIFdn transgene was detected by using the HIFdn forw and FLAG rev primers (see above).
Histology and Immunohistochemistry. Embryos were dissected, embedded in Tissue-Tek (Sakura, Giessen, Germany), and frozen on dry ice-isopentane. Frozen sections (8-12 µm) were stained using the Vectastain-Peroxidase kit (Vector Laboratories, Burlingame, USA).
Peroxidase activity was visualized using the AEC substrate kit as suggested by the supplier paraformaldehyde/0.1% glutaraldehyde at 4°C. Then they were cleared in 50% and 70% glycerol before photographic documentation using a dissecting microscope (Stemi SV11, Zeiss, Germany) with digital camera (DSC-S75, Sony).
Immunofluorescence staining. HUE cells were seeded on glass cover slips and transiently transfected with pcDNA3/HIF-2 -FLAG or pcDNA3/HIFdn-FLAG using Superfect transfection reagent (Qiagen, Hilden, Germany). 48 h after transfection, the cells were fixed and stained using the mouse monoclonal anti-FLAG M2 antibody (diluted 1:500, Sigma, St. 
Results
A deletion mutant of HIF-2 was generated ( Figure 1A ) that lacked the C-terminal transactivation domains, the oxygen dependent destruction domain (ODD) and part of the Nterminal DNA binding domain 17 . 
transiently transfected with HIF-2 or HIFdn expression vectors. Immunofluorescence for the FLAG epitope revealed that HIF-2 was exclusively located in the nuclei of transfected cells, whereas HIFdn was distributed in the cytoplasm, most likely because of the deletion of a nuclear localization signal ( Figure 1E ).
To investigate the potential effects of blocking HIF activity in the developing vascular system, we generated transgenic mice that expressed HIFdn in an endothelial cell-specific manner. A cDNA for HIFdn was fused to promoter/enhancer elements of the murine flk-1 gene (flk-1 p/e, Figure 2A ). The flk-1 p/e directs the expression of transgenes specifically to the endothelium in mouse embryos, starting at around E8.0 16, 35, 36 . Due to embryonic lethality, transgenic mouse lines could not be generated. We therefore analysed embryos that developed from microinjected oocytes. In total, 63 transgenic embryos were dissected between E10.5 and E14.5. About 30% (19 of 63) of the flk-1 p/e-HIFdn transgenic embryos were growth retarded and showed severe vascular disorganization. Most transgenic embryos were alive and had beating hearts at E10.5. We focused our analysis on embryos at E10.5 and E11.5, because embryonic lethality increased at later developmental stages. Transgene expression was confirmed by RT-PCR using a specific primer for the FLAG-tag which allowed to distinguish between transgenic HIFdn and endogenous HIF-2 expression ( Figure 2F ).
Immunohistochemistry for the FLAG epitope revealed transgene expression in blood vessels ( Figure 2G,H) . As expected, not all transgenics expressed HIFdn, most likely because the transgene was integrated in transcriptionally inactive regions of the genome. Transgene expression correlated with the observed phenotype, whereas non-expressers showed no morphological abnormalities (data not shown). In the following, the term ´HIFdn transgenic embryos´ will be used to refer to the flk-1 p/e-HIFdn transgenic embryos that displayed the morphological abnormalities and expressed the transgene.
Whereas wild-type embryos had a well perfused and hierarchically structured yolk sac (Figure 2B ), the yolk sac vasculature of HIFdn transgenic embryos was disarranged without large caliber vessels, and lacked perfusion ( Figure 2C ). The HIFdn transgenic embryos appeared pale and showed focal hemorrhage ( Figure 2E) . As compared to wild-type littermates ( Figure 2D ), they were severely growth retarded ( Figure 2E,I ). The intra-embryonic vasculature appeared overall disarranged, especially in the cephalic region where the branches of the internal carotid artery were not visible ( Figure 2E ). Moreover, in most transgenic embryos, pericardial edema were detectable Also, the intersomitic vessels were established in wild-type as well as in HIFdn transgenic embryos at this stage (data not shown). Heart development in HIFdn transgenic mouse embryos was retarded. Only a primitive linear heart tube was observed ( Figure 3D ,E), whereas wild-type littermates had an S-shaped heart tube, bringing atria and ventricle into close proximity ( Figure 3C ). Moreover, Pecam-1 staining of the endocardial layer revealed a patchy and irregular pattern as compared to wild-type embryos ( Figure 3D ).
The vessels in the head were visualized by Pecam-1 or Flk-1 staining in wild-type animals ( Figure 4A ,C, and data not shown). In HIFdn transgenics, the perineural vascular plexus (PNV) formed normally, but failed to invade the neuropithelium (Figure 4B,D) .
Analysis of serial sections of whole embryos confirmed that the neuroepithelium of the brain and spinal cord remained avascular, demonstrating that sprouting angiogenesis did not occur (data not shown). The hearts of wild-type embryos developed a solid myocardium with For personal use only. on October 31, 2017. by guest www.bloodjournal.org From were also examined. As expected, VEGF expression levels were unaltered in HIFdn transgenic embryos embryos ( Figure 5A ), because VEGF is mainly expressed by nonendothelial cells in vivo 39, 40 . Angiopoietin-1 transcript levels were also similar in wild-type and transgenic embryos (data not shown).
Discussion
Blood vessel growth in response to hypoxia is mediated by HIFs. In addition to hypoxia, growth factor signaling via MAP kinases leads to the stabilization and activation of HIF. HIF-1 stimulates the expression of VEGF and other potent angiogenic factors 41, 42 . Endothelial cells respond to hypoxia by upregulating Tie-2 and VEGF receptors [43] [44] [45] [46] . Prime candidates for intrinsic regulators of angiogenesis are HIF-1 which regulates endothelial genes in response to hypoxia 18 , and HIF-2 which stimulates tie-2 and flk-1 promoter activity in vitro 7, [15] [16] [17] . However, the endothelial cell-specific ablation of HIF-1 did not interfere with normal vascular development, whereas it impaired tumor angiogenesis in adult mice 22 . Similarly, because HIF-2 null embryos did not show consistent vascular abnormalities [23] [24] [25] [26] , an endothelial cell intrinsic function of HIF-2 during development appeared unlikely. We suspected that the loss of HIF-1 function can be partially compensated by HIF-2, and vice versa. To circumvent the problem of functional redundancy, we designed a dominant negative approach that interferes with the endothelial activity of both HIF-1 and HIF-2. The HIFdn mutant used in our study was highly specific because it interfered with HIF target genes known from in vitro studies but did not with other endothelial markers, such as Pecam-1, Tie-1 and VE-cadherin.
HIFdn transgenic embryos showed multiple cardiovascular defects. Endothelial cells and primitive vessels were formed, but the vascular network remained immature and disorganized, indicating that the initial phase of vessel formation (vasculogenesis) was not
disturbed. The absence of a vasculogenesis phenotype was expected because the flk-1 p/e elements used in our study directs HIFdn transgene expression to committed endothelial cells, but is not active in progenitor cells of the hemangioblastic lineage 16, 35 . Whether HIFs have a cell autonomous function in endothelial progenitor committment/proliferation during vasculogenesis, remains to be determined.
The observed phenotypic abnormalities in transgenic HIFdn mouse embryos included defects in yolk sac circulation, sprouting angiogenesis and vascular remodeling, especially in the head region. Also, heart development was impaired as the endocardium was disarranged, the ventricle walls were thin, and trabeculae were poorly formed. Because placental vascularization was not impaired by the inhibition of endothelial HIF activity, it can be excluded that the observed embryonic phenotype is secondary to defective placentation, as it was observed in ARNT null mice 37, 38 . The inhibition of HIF activity in endothelial cells had a less severe effect on vascular development and embryonic survival than the loss of HIF-1 expression alone in all cells, which results in embryonic lethality by E10.5 20 , confirming that there is also a requirement for HIF-1 in non-endothelial cells for normal vascular development to occur.
The defects observed in HIFdn transgenic embryos showed remarkable similarities to the phenotypes of tie-2 knockout mice. Tie-2 is an essential receptor tyrosine kinase, expressed by endothelial cells during vascular morphogenesis. Tie-2 null mice display defects in vascular remodeling, sprouting angiogenesis, and ventricular trabeculation. These malformations might result from defective perivascular cell recruitment 47, 48 and/or endothelial cell survival 47, 49, 50 . Tie-2 serves as receptor for angiopoietin-1 (ang-1) and Figure 1 ).
The observation that Tie-2 is completely down-regulated in transgenic HIFdn embryos argues against the possibility that the expression levels of the HIFdn transgene were not high enough to block Flk-1 transcription completely.
In conclusion, we provide direct functional evidence that HIF activity in the developing endothelium is essential for embryonic cardiovascular development. Although endothelial HIFs control a broad spectrum of genes in endothelial cells 18 , a particularly critical target is the essential endothelial receptor tyrosine kinase, Tie-2. 
